SCHEMBL22862638

SCHEMBL22862638

Cn1c(=O)n(C)c2cc(Cn3cnc(C4CC4)c3C3CCCC3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRIM24 O15164 2/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ LMNA P02545 3/20 0.37
▸ HTT P42858 3/20 0.37
▸ UBE2N P61088 2/20 0.37
▸ BRD1 O95696 2/20 0.36
▸ BRPF1 P55201 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ PKM P14618 1/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ RAD52 P43351 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ MAPK1 P28482 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29490202 1.00 TRIM24 (0.42) TRIM24SMN1; SMN2L3MBTL1TSHRLMNA
SCHEMBL22862953 1.00 TRIM24 (0.42) TRIM24SMN1; SMN2L3MBTL1TSHRLMNA
SCHEMBL29490310 1.00 TRIM24 (0.42) TRIM24SMN1; SMN2L3MBTL1TSHRLMNA
SCHEMBL22862779 0.98 TRIM24 (0.40) TRIM24SMN1; SMN2L3MBTL1TSHRLMNA
SCHEMBL24704281 0.87 SMN1; SMN2 (0.35) TRIM24SMN1; SMN2L3MBTL1TSHRLMNA
SCHEMBL22862855 0.86 SMN1; SMN2 (0.37) TRIM24SMN1; SMN2L3MBTL1TSHRLMNA
SCHEMBL29490249 0.86 SMN1; SMN2 (0.37) TRIM24SMN1; SMN2L3MBTL1TSHRLMNA
SCHEMBL22862856 0.86 SMN1; SMN2 (0.37) TRIM24SMN1; SMN2L3MBTL1TSHRLMNA
SCHEMBL29490177 0.86 SMN1; SMN2 (0.37) TRIM24SMN1; SMN2L3MBTL1TSHRLMNA
SCHEMBL22862432 0.81 MAPK14 (0.42) TRIM24SMN1; SMN2L3MBTL1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220389028-A1 BAX INHIBITORS AND USES THEREOF CASE WESTERN RESERVE UNIVERSITY 2022-12-08 — — US disclosed
WO-2021002986-A2 BAX INHIBITORS AND USES THEREOF CASE WESTERN RESERVE UNIVERSITY (US) 2021-01-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220389028-A1 BAX INHIBITORS AND USES THEREOF BAX, TMBIM6, BCL2 TRIM24 2607/4885SMN1; SMN2 2633/4885L3MBTL1 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback